Two experimental vaccines show promise in protecting against infection with the "mono" virus, which also causes cancer and has been implicated as a potential trigger of multiple sclerosis, a new paper reports.
May 8, 2022
0
28
Mayo Clinic researchers say senolytic drugs can boost a key protein in the body that protects older people against aspects of aging and a range of diseases. Their findings, which are published in eBioMedicine, demonstrate ...
Mar 15, 2022
0
90
The World Health Organization has given emergency approval to a coronavirus vaccine made by U.S.-based Novavax and the Serum Institute of India, paving the way for its inclusion in the U.N.-backed program to get such vaccines ...
Dec 17, 2021
0
4
Cancer cells can become resistant to treatments through adaptation, making them notoriously tricky to defeat and highly lethal. Cold Spring Harbor Laboratory (CSHL) Cancer Center Director David Tuveson and his team investigated ...
Jun 22, 2021
0
19
Alzheimer's disease is the most common form of dementia and is characterized by neurodegeneration in regions of the brain involved in memory and learning. Amyloid beta and tau are two toxic proteins that build up in disease ...
Jun 14, 2021
0
19
University of California, Irvine biologists have developed a new genetically engineered mouse model, that unlike its predecessors, is based on the most common form of Alzheimer's disease. The advance holds promise for making ...
Apr 27, 2021
1
50
As people get older, their neural stem cells lose the ability to proliferate and produce new neurons, leading to a decline in memory function. Researchers at the University of Zurich have now discovered a mechanism linked ...
Feb 24, 2021
0
233
More than 50% of all vaccines are wasted due to errors in transportation or storage, according to the World Health Organization. A research team led by Northwestern and Cornell universities has developed a new manufacturing ...
Feb 3, 2021
0
95
SARS-CoV-2, the new coronavirus behind the current pandemic, infects humans by binding its surface-exposed spike proteins to ACE2 receptors exposed on the cell membranes.
Feb 3, 2021
0
8
Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work—though not as well—against new mutated versions of the virus circulating ...
Jan 28, 2021
0
39
